A graduate of CDL-Seattle, Diag-Nose.io aims to enhance respiratory disease diagnosis and treatment through advanced AI-driven solutions....
The strategic acquisition enhances Telix’s next-generation radiopharmaceutical capabilities, strengthening its position in precision oncology and beyond....
The latest updates on the market rollout of Ryoncil® and insights into the company’s expanding pipeline of innovative therapies....
The collaboration aims to provide millions of patients with real-time access to their blood test results, enhancing healthcare convenience and personalized care....
The collaboration aims to enhance immunotherapy development by leveraging artificial intelligence for targeted and personalized treatment approaches....
The funding will help scale access to telehealth-based opioid use disorder care across the U.S., improving patient reach and support....
Early findings in a mice model show encouraging potential for novel therapeutic approaches in brain cancer....
Expanding adoption of innovative immune modulation therapy to enhance patient outcomes....
Lecanemab-irmb receives approval as a maintenance therapy, offering new hope for early-stage Alzheimer’s patients....
Tevogen Bio Expands AI Partnership with Microsoft to Advance PredicTcell Technology ...
